India Infectious Disease Testing Market 2018: Supplier Strategies, Test Volume and Sales Forecasts, Technology and Instrumentation Review – ResearchAndMarkets.com

11-Apr-2018 Intellasia | BusinessWire | 12:52 AM Print This Post

DUBLIN–(BUSINESS WIRE)–The “2018
India Infectious Disease Testing Market: Supplier Strategies, Test
Volume and Sales Forecasts, Technology and Instrumentation Review”

report has been added to ResearchAndMarkets.com’s
offering.

The report reviews current and emerging assays; analyzes potential
applications of innovative diagnostic technologies; forecasts volume and
sales for over 100 infectious disease tests; provides test volume
estimates by method (molecular, serology/immunodiagnostics,
culture/microscopy); profiles leading players and potential market
entrants; and suggests alternative business expansion strategies for
suppliers.

This comprehensive report will assist diagnostics industry executives,
as well as companies planning to diversify into the dynamic and rapidly
expanding infectious disease testing market, in evaluating emerging
opportunities and developing effective business strategies.

The infectious disease testing is one of the most rapidly growing
segments of the in vitro diagnostics industry, and the greatest
challenge facing suppliers during this decade. Among the main driving
forces is continuing spread of AIDS, which remains the world’s major
health threat and a key factor contributing to the rise of opportunistic
infections; threat of bioterrorism; advances in molecular diagnostic
technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for
others the causative microorganisms are present in minute concentrations
long before the occurrence of first clinical symptoms, recent advances
in genetic engineering and detection technologies are creating exciting
opportunities for highly sensitive, specific and cost-effective products.

Companies Mentioned

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech/Leica
  • Lonza
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher/Life Technology
  • Wallac/PE
  • Wako

Key Topics Covered

  1. Infectious Diseases Analyzed
  2. Current and Emerging Products
  3. Technology Review
  4. Opportunities and Strategic Recommendations
  5. Competitive Assessments

For more information about this report visit https://www.researchandmarkets.com/research/55xxzz/india_infectious?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Infectious
Disease Testing

 


Category: BusinessWire, PRAsia

Print This Post

Comments are closed.